Palvella Therapeutics raises $230 million in upsized stock offering Mar 2, 2026 07:30AM
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares Mar 2, 2026 07:30AM
Palvella Therapeutics prices $200 million stock offering at $125 per share Feb 25, 2026 07:57PM
Palvella Therapeutics Announces Pricing of Upsized Public Offering Feb 25, 2026 07:57PM
Palvella Therapeutics launches $150 million stock offering Feb 24, 2026 04:06PM


Feb 24, 2026 04:05PM Palvella Therapeutics Announces Proposed Public Offering
Feb 24, 2026 01:56PM Palvella Therapeutics (PVLA) PT Raised to $267 at TD Cowen
Feb 2, 2026 05:20AM Palvella Therapeutics (PVLA) PT Raised to $190 at TD Cowen
Jan 8, 2026 09:20AM TD Cowen on Palvella Therapeutics' (PVLA) SELVA Data Preview: 'High Conviction for Success'
Dec 16, 2025 06:09AM Palvella Therapeutics (PVLA) PT Raised to $133 at TD Cowen
Nov 5, 2025 05:31PM Palvella Therapeutics (PVLA) PT Raised to $97 at TD Cowen
Feb 25, 2025 08:00AM Palvella Therapeutics to Present at the TD Cowen 45th Annual Healthcare Conference
Feb 5, 2025 05:29AM TD Cowen Starts Palvella Therapeutics (PVLA) at Buy
Dec 13, 2024 02:55PM Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million